-
Mashup Score: 2New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT - Eyetube - 20 day(s) ago
How do endophthalmitis rates after intravitreal injection differ after using povidone-iodine compared with chlorhexidine? Moderator Sruthi Arepalli, MD, hears from panelists Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH, about a recent peer-reviewed…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Rising Stars in Retina: Jesse D. Sengillo, MD - Retina Today - 23 day(s) ago
Retina Today: When did you first know that you wanted to become a retina specialist? I had an early interest in the field of retina, and I even app
Source: retinatoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4icn_podcast - 26 day(s) ago
By: Natalie Huang, MD; Christina Y. Weng, MD, MBA This continuing medical education (CME) activity captures content from a live symposium. This supplement summarizes a presentation on how to incorporate new and emerging therapies for neovascular age-related macular degeneration and diabetic eye disease into your clinic to alleviate the high treatment burden and other barriers to optimal outcomes that patients experience. This certified CME activity is designed for retina specialists. Expiration Date:
Source: evolvemeded.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0BYOOVIZ® (ranibizumab nuna) and the Age of Biosimilars - Eyetube - 28 day(s) ago
What do retina specialists need to know about biosimilars in general and BYOOVIZ in particular? Sit down with Anat Loewenstein, MD, and David Brown, MD, as they explore this new era in retina.
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 6Leveraging Siglec Receptors to Repolarize Macrophages for the Treatment of Geographic Atrophy - Retina Today - 29 day(s) ago
How moving beyond complement targets may lead to true maintenance of vision and greater reduction in GA lesion growth rates.
Source: retinatoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 32Retina Today - 30 day(s) ago
Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight…
Source: retinatoday.comCategories: General Medicine News, OphthalmologyTweet-
Taken together, the articles in this issue are designed to help refocus our attention on the pandemic that has plagued our offices for decades: An estimated 1.49 million people have late-stage #AMD (#wetAMD or GA). Read the new issue: https://t.co/KQ11sYgQAL #diabeticeyedisease https://t.co/tj5NoOopnF
-
-
Mashup Score: 0GATHER2 Data at 1 and 2 Years - Eyetube - 1 month(s) ago
What are the most important data to know from the GATHER2 study? Clinical Minute: Retina host Ramin Tadayoni, MD, PhD, is joined by Arshad Khanani, MD, MA, to review the 1- and 2-year results of the GATHER2 study. At the end of the episode, Dr. Khanani…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 82icn_podcast - 1 month(s) ago
By: Natalie Huang, MD; Christina Y. Weng, MD, MBA This continuing medical education (CME) activity captures content from a live symposium. This supplement summarizes a presentation on how to incorporate new and emerging therapies for neovascular age-related macular degeneration and diabetic eye disease into your clinic to alleviate the high treatment burden and other barriers to optimal outcomes that patients experience. This certified CME activity is designed for retina specialists. Expiration Date:
Source: evolvemeded.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 54icn_podcast - 1 month(s) ago
By: Natalie Huang, MD; Christina Y. Weng, MD, MBA This continuing medical education (CME) activity captures content from a live symposium. This supplement summarizes a presentation on how to incorporate new and emerging therapies for neovascular age-related macular degeneration and diabetic eye disease into your clinic to alleviate the high treatment burden and other barriers to optimal outcomes that patients experience. This certified CME activity is designed for retina specialists. Expiration Date:
Source: evolvemeded.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5Practice Trends in Dry AMD and Geographic Atrophy - Retina Today - 1 month(s) ago
The EURETINA Clinical Trends Survey has been carried out over the past several years, with the most recent survey conducted in the fall of 2022, coinc
Source: retinatoday.comCategories: General Medicine News, OphthalmologyTweet-
How are you approaching dry AMD and GA in your practice? Read about clinical trends, disease ID and progression, outcomes targets, & more from Prof Nicole Eter, Prof Sandrine Zweifel, Prof Ursula Schmidt-Erfurth, Prof Eleonora Lad, & Prof Veeral S. Sheth. https://t.co/G2sgQ1qWjI https://t.co/XsNHLWvdbZ
-
How do endophthalmitis rates after IVI differ after using povidone-iodine compared with chlorhexidine? #Retina specialists Drs. Arepalli, Dedania, and Soares review recent literature on the topic: https://t.co/SfbpsD3HeH